Kathrin Rieger

Summary

Affiliation: Humboldt University
Country: Germany

Publications

  1. Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation
    Wolfgang Knauf
    Medical Clinic III Hematology Oncology and Transfusion Medicine University Clinic Benjamin Franklin of Freie Universitaet Berlin Germany
    Leuk Lymphoma 45:2455-8
  2. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation
    Kathrin Rieger
    Department of Hematology, Oncology and Transfusion Medicine, Charité Campus Benjamin Franklin, University School of Medicine, Berlin, Germany
    Exp Hematol 33:605-11
  3. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
    Kathrin Rieger
    Department of Hematology, Oncology and Transfusion Medicine, Charité Campus Benjamin Franklin, Hindenburgdamm 30, D 12200 Berlin, Germany
    Blood 107:1717-23
  4. The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius
    Olaf Penack
    Department of Hematology, Oncology, and Transfusion Medicine, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
    Transpl Immunol 18:85-7
  5. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy
    Philipp Kiewe
    Department of Hematology, Oncology and Transfusion Medicine, Benjamin Franklin University Hospital, Free University of Berlin, Berlin, Germany
    Leuk Lymphoma 44:1815-8
  6. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment
    Thomas Fietz
    Hematol J 5:451-2

Collaborators

Detail Information

Publications6

  1. Remission induction using alemtuzumab can permit chemotherapy-refractory chronic lymphocytic leukemia (CLL) patients to undergo allogeneic stem cell transplantation
    Wolfgang Knauf
    Medical Clinic III Hematology Oncology and Transfusion Medicine University Clinic Benjamin Franklin of Freie Universitaet Berlin Germany
    Leuk Lymphoma 45:2455-8
    ..Two patients reached complete remission (CR); one patient attained stable partial remission (PR). These heavily pre-treated refractory patients gained substantial clinical benefit from alemtuzumab, and received successful allografts...
  2. Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation
    Kathrin Rieger
    Department of Hematology, Oncology and Transfusion Medicine, Charité Campus Benjamin Franklin, University School of Medicine, Berlin, Germany
    Exp Hematol 33:605-11
    ..CONCLUSION: Even though HSC have been found to differentiate into a variety of nonhematological cell types, they usually do not differentiate into MSC after allogeneic transplantation...
  3. Mucosal FOXP3+ regulatory T cells are numerically deficient in acute and chronic GvHD
    Kathrin Rieger
    Department of Hematology, Oncology and Transfusion Medicine, Charité Campus Benjamin Franklin, Hindenburgdamm 30, D 12200 Berlin, Germany
    Blood 107:1717-23
    ..The determination of FOXP3+/CD8+ ratio can be a helpful tool to discriminate GvHD from infectious inflammation after allogeneic stem cell transplantation...
  4. The type of ATG matters -- natural killer cells are influenced differentially by Thymoglobulin, Lymphoglobulin and ATG-Fresenius
    Olaf Penack
    Department of Hematology, Oncology, and Transfusion Medicine, Charité Campus Benjamin Franklin, Hindenburgdamm 30, 12200 Berlin, Germany
    Transpl Immunol 18:85-7
    ..Randomized trials addressing the impact of different ATGs on lymphocyte subpopulations in the clinical setting are urgently warranted...
  5. Progressive multifocal leukoencephalopathy with detection of JC virus in a patient with chronic lymphocytic leukemia parallel to onset of fludarabine therapy
    Philipp Kiewe
    Department of Hematology, Oncology and Transfusion Medicine, Benjamin Franklin University Hospital, Free University of Berlin, Berlin, Germany
    Leuk Lymphoma 44:1815-8
    ..The question remains whether serologic screening for JC virus in patients with chronic lymphoproliferative disease undergoing intense chemotherapy might be valuable once sufficient antiviral treatment has been established...
  6. Alemtuzumab (Campath 1H) in hairy cell leukaemia relapsing after rituximab treatment
    Thomas Fietz
    Hematol J 5:451-2